AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2022
Apr 6, 2022
32853_dirs_2022-04-06_13ea5631-f9d9-4a10-b3f8-1ebe4b3e922c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-04
Reporting Person: Casdin Partners Master Fund, L.P. (Director)
Reporting Person: Casdin Capital, LLC (Director, 10% Owner)
Reporting Person: Casdin Partners GP, LLC (Director, 10% Owner)
Reporting Person: Casdin Private Growth Equity Fund II, L.P. (Director, 10% Owner)
Reporting Person: Casdin Private Growth Equity Fund II GP, LLC (Director, 10% Owner)
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30